Cargando…
Hypoxia-active nanoparticles used in tumor theranostic
Hypoxia is a hallmark of malignant tumors and often correlates with increasing tumor aggressiveness and poor treatment outcomes. Therefore, early diagnosis and effective killing of hypoxic tumor cells are crucial for successful tumor control. There has been a surge of interdisciplinary research aime...
Autores principales: | Wang, Yaqin, Shang, Wenting, Niu, Meng, Tian, Jie, Xu, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535445/ https://www.ncbi.nlm.nih.gov/pubmed/31190820 http://dx.doi.org/10.2147/IJN.S196959 |
Ejemplares similares
-
Targeted Theranostic Nanoparticles for Brain Tumor Treatment
por: Mendes, Maria, et al.
Publicado: (2018) -
Surface-enhanced Raman nanoparticles for tumor theranostics applications
por: Li, Yangyang, et al.
Publicado: (2018) -
Innate tumor-targeted nanozyme overcoming tumor hypoxia for cancer theranostic use
por: Veroniaina, Hanitrarimalala, et al.
Publicado: (2021) -
Theranostics Applications of Nanoparticles in Cancer Immunotherapy
por: Liu, Yihai, et al.
Publicado: (2018) -
Magnetic Nanoparticles in Cancer Theranostics
por: Gobbo, Oliviero L., et al.
Publicado: (2015)